BMRN - Company ID 0001048477
BIOMARIN PHARMACEUTICAL INC (BMRN) reported revenue of $3.22B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $3.22B | +12.9% |
| FY 2024 | $2.85B | +18.0% |
| FY 2023 | $2.42B | +15.4% |
| FY 2022 | $2.10B | +13.5% |
| FY 2021 | $1.85B | -0.8% |
| FY 2020 | $1.86B | +9.2% |
| FY 2019 | $1.70B | +14.3% |
| FY 2018 | $1.49B | +13.5% |
| FY 2017 |
BIOMARIN PHARMACEUTICAL INC (BMRN) reported revenue of $3.22B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, BIOMARIN PHARMACEUTICAL INC's revenue grew from $441.36M to $3.22B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.31B |
| +17.6% |
| FY 2016 | $1.12B | +25.5% |
| FY 2015 | $889.89M | +18.8% |
| FY 2014 | $749.28M | +36.6% |
| FY 2013 | $548.49M | +9.5% |
| FY 2012 | $500.72M | +13.5% |
| FY 2011 | $441.36M | - |